시장보고서

상품코드

1493358

미국의 자가면역질환 진단 시장 규모, 점유율, 동향 분석 리포트 : 유형별, 검사 유형별, 최종 용도별, 부문별 예측(2024-2030년)

U.S. Autoimmune Disease Diagnostics Market Size, Share & Trends Analysis Report By Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics), By Test Type, By End-use, And Segment Forecasts, 2024 - 2030

발행일: 2024년 05월 | 리서치사:

Grand View Research | 페이지 정보: 영문 125 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

미국의 자가면역질환 진단 시장 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 미국의 자가면역질환 진단 시장 규모는 2030년까지 30억 1,000만 달러에 달하며, 2024-2030년의 CAGR은 5.2%로 성장할 것으로 예측되고 있습니다.

자가면역 질환의 발병률 증가와 진단 툴 및 진단 기술의 기술 발전으로 인해 시장 성장이 크게 촉진되고 있습니다.

자가면역질환에 대한 의료진과 환자들의 인식이 높아지면서 진단 및 검진율이 높아지고 있습니다. 공중보건 활동, 교육 캠페인, 옹호 활동으로 자가면역질환의 징후와 증상에 대한 인식이 높아지면서 조기 진단과 치료를 받으려는 사람들이 늘어나고 있습니다. 고위험군을 대상으로 한 선별검사 프로그램도 자가면역질환을 조기에 발견하는 데 기여하고 있습니다.

세계 헬스케어 지출 증가와 자가면역질환으로 인한 의료시스템의 부담 증가는 첨단 진단 솔루션에 대한 수요를 촉진하고 있습니다. 정부와 민간단체들은 자가면역질환이 야기하는 문제를 해결하기 위해 의료 인프라 및 연구개발에 투자하고 있습니다. 이러한 투자는 진단 기술 혁신을 촉진하고 자가면역질환 환자들이 양질의 진단 서비스를 이용할 수 있도록 돕고 있습니다.

미국 자가면역질환 진단 시장 보고서 하이라이트

초음파, MRI, PET 스캔과 같은 첨단 영상진단 기술의 부상으로 인해 국소 자가면역질환 진단 유형이 2023년 66.0%의 점유율로 시장을 장악했습니다.
항핵 항체 검사 유형은 2023년 가장 큰 시장 점유율을 차지하고 예측 기간 중 가장 빠른 성장을 보일 것으로 예상됩니다.
정확하고 정밀한 검사 방법에 대한 수요가 증가함에 따라 병원 최종 사용 분야가 2023년 시장을 장악했습니다.
2023년 11월, 프로젠텍 진단(Progentec Diagnostics)과 메이요 클리닉 연구소(Mayo Clinic Laboratories)는 자가면역질환의 조기 발견 및 치료를 위한 프로젠텍의 특허 받은 바이오마커 혈액검사 제품군을 상용화하기 위한 전략적 제휴를 발표했습니다. 이번 제휴는 미국 및 일부 국제 시장에서 환자와 임상의의 접근성을 향상시키기 위한 것입니다.

주요 시장 참여 기업에 의한 최근 동향과 영향 분석
기업/경쟁 분류
벤더 구도
기업 개요
- Medtronic
- Boston Scientific Corporation
- Johnson &Johnson Service Inc.(Ethicon, Inc.)
- AngioDynamics
- Bioventus Inc.(Misonix Inc.)
- EDAP TMS
- Chongqing Haifu Medical Technology Co., Ltd
- Mermaid Medical
- HealthTronics, Inc.
- HS Hospital Service SpA

KSA 24.06.20

U.S. Autoimmune Disease Diagnostics Market Growth & Trends:

The U.S. autoimmune disease diagnostics market size is anticipated to reach USD 3.01 billion by 2030, growing at a CAGR of 5.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising incidence of autoimmune diseases and increasing technological advancements in diagnostic tools and techniques are significantly driving the growth of the market.

Increasing awareness about autoimmune diseases among healthcare professionals and patients has led to a higher rate of diagnosis and screening. Public health initiatives, educational campaigns, and advocacy efforts have raised awareness about the signs and symptoms of autoimmune diseases, prompting individuals to seek early diagnosis and treatment. Screening programs aimed at high-risk populations have also contributed to the early detection of autoimmune conditions.

The increasing healthcare expenditure globally, coupled with the growing burden of autoimmune diseases on healthcare systems, has fueled the demand for advanced diagnostic solutions. The government and private organizations are investing in healthcare infrastructure, research, and development to address the challenges posed by autoimmune diseases. This investment drives innovation in diagnostic technologies and promotes access to quality diagnostic services for patients with autoimmune conditions.

U.S. Autoimmune Disease Diagnostics Market Report Highlights:

Localized autoimmune disease diagnostics type dominated the market with a 66.0% share in 2023 owing to the rising advanced imaging techniques, such as ultrasound, MRI, and PET scans, which allow for detailed visualization of affected tissues or organs.
The antinuclear antibody test type segment held the largest market share in 2023 and is anticipated to witness the fastest growth over the forecast period.
The hospitals end-use segment dominated the market in 2023 owing to the growing need for accurate and precise testing methods.
In November 2023, Progentec Diagnostics and Mayo Clinic Laboratories announced a strategic partnership to commercialize Progentec's range of patented biomarker blood tests for the early detection and treatment of autoimmune disorders. The partnership seeks to improve accessibility for patients and clinicians in the United States and a few international markets.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Type
- 1.2.2. Test Type
- 1.2.3. End-use
- 1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Test outlook
- 2.2.2. Test type outlook
- 2.2.3. End-use outlook
2.3. Competitive Insights

Chapter 3. U.S. Autoimmune Disease Diagnostics Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Presence of research funding programs
  - 3.2.1.2. Presence of favorable government initiatives
  - 3.2.1.3. Growing patient awareness levels
  - 3.2.1.4. Technological innovation in the form of lab automation
- 3.2.2. Market restraint analysis
  - 3.2.2.1. Slow diagnostic result turnaround times and lack of skilled
3.3. U.S. Autoimmune Disease Diagnostics Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's Five Forces
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Technological landscape
  - 3.3.2.3. Economic landscape

Chapter 4. U.S. Autoimmune Disease Diagnostics Market: Type Estimates & Trend Analysis

4.1. Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. Autoimmune Disease Diagnostics Market by Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 4.4.1. U.S. Autoimmune Disease Diagnostics
  - 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.1.2. Rheumatoid arthritis
  - 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.1.3. Ankylosing spondylitis diagnostics
  - 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.1.4. Systemic lupus erythematosus (SLE)
  - 4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.1.5. Others
  - 4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2. Localized autoimmune disease diagnostics
  - 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.2.2. Multiple sclerosis
  - 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.2.3. Type 1 diabetes
  - 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.2.4. Hashimoto's Thyroiditis
  - 4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.2.5. Idiopathic thrombocytopenic purpura
  - 4.4.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.2.6. Others
  - 4.4.2.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Autoimmune Disease Diagnostics Market: Test Type Estimates & Trend Analysis

5.1. Test Type Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. Autoimmune Disease Diagnostics Market by Test Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 5.4.1. Antinuclear antibody tests
  - 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2. Autoantibody tests
  - 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.3. C-reactive Protein (CRP)
  - 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.4. Complete blood count (CBC)
  - 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.5. Urinalysis
  - 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.6. Others
  - 5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. Autoimmune Disease Diagnostics Market: End-use Estimates & Trend Analysis

6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. U.S. Autoimmune Disease Diagnostics Market by End-use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 6.4.1. Hospitals
  - 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.2. Diagnostic centers
  - 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.3. Others
  - 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. U.S. Autoimmune Disease Diagnostics Market: Region Estimates & Trend Analysis

7.1. Regional Market Share, 2023 & 2030
7.2. U.S. Autoimmune Disease Diagnostics Market by Region Outlook
7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 7.3.1. West
  - 7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 7.3.2. Midwest
  - 7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 7.3.3. Northeast
  - 7.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 7.3.4. Southwest
  - 7.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 7.3.5. Southeast
  - 7.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key company heat map analysis, 2023
8.4. Company Profiles
- 8.4.1. Medtronic
  - 8.4.1.1. Company overview
  - 8.4.1.2. Financial performance
  - 8.4.1.3. Product benchmarking
  - 8.4.1.4. Strategic initiatives
- 8.4.2. Boston Scientific Corporation
  - 8.4.2.1. Company overview
  - 8.4.2.2. Financial performance
  - 8.4.2.3. Product benchmarking
  - 8.4.2.4. Strategic initiatives
- 8.4.3. Johnson & Johnson Service Inc. (Ethicon, Inc.)
  - 8.4.3.1. Company overview
  - 8.4.3.2. Financial performance
  - 8.4.3.3. Product benchmarking
  - 8.4.3.4. Strategic initiatives
- 8.4.4. AngioDynamics
  - 8.4.4.1. Company overview
  - 8.4.4.2. Financial performance
  - 8.4.4.3. Product benchmarking
  - 8.4.4.4. Strategic initiatives
- 8.4.5. Bioventus Inc. (Misonix Inc.)
  - 8.4.5.1. Company overview
  - 8.4.5.2. Financial performance
  - 8.4.5.3. Product benchmarking
  - 8.4.5.4. Strategic initiatives
- 8.4.6. EDAP TMS
  - 8.4.6.1. Company overview
  - 8.4.6.2. Financial performance
  - 8.4.6.3. Product benchmarking
  - 8.4.6.4. Strategic initiatives
- 8.4.7. Chongqing Haifu Medical Technology Co., Ltd
  - 8.4.7.1. Company overview
  - 8.4.7.2. Financial performance
  - 8.4.7.3. Product benchmarking
  - 8.4.7.4. Strategic initiatives
- 8.4.8. Mermaid Medical
  - 8.4.8.1. Company overview
  - 8.4.8.2. Financial performance
  - 8.4.8.3. Product benchmarking
  - 8.4.8.4. Strategic initiatives
- 8.4.9. HealthTronics, Inc.
  - 8.4.9.1. Company overview
  - 8.4.9.2. Financial performance
  - 8.4.9.3. Product benchmarking
  - 8.4.9.4. Strategic initiatives
- 8.4.10. H.S. Hospital Service S.p.A.
  - 8.4.10.1. Company overview
  - 8.4.10.2. Financial performance
  - 8.4.10.3. Product benchmarking
  - 8.4.10.4. Strategic initiatives

미국의 자가면역질환 진단 시장 규모, 점유율, 동향 분석 리포트 : 유형별, 검사 유형별, 최종 용도별, 부문별 예측(2024-2030년)

U.S. Autoimmune Disease Diagnostics Market Size, Share & Trends Analysis Report By Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics), By Test Type, By End-use, And Segment Forecasts, 2024 - 2030

미국의 자가면역질환 진단 시장 성장과 동향 :

미국 자가면역질환 진단 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 미국의 자가면역질환 진단 시장 변수, 동향, 범위

제4장 미국의 자가면역질환 진단 시장 : 유형 추정·동향 분석

제5장 미국의 자가면역질환 진단 시장 : 검사 유형 추정·동향 분석

제6장 미국의 자가면역질환 진단 시장 : 최종 용도 추정·동향 분석

제7장 미국의 자가면역질환 진단 시장 : 지역 추정·동향 분석

제8장 경쟁 구도